Victor A. Chow

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Filippo Milano, Steven A. Pergam, Hu Xie et al. · Blood · 2011 · 105 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant

Michael Scordo, Trent Wang, Kwang Woo Ahn et al. · JAMA Oncology · 2021 · 81 citations · Full text

Medicine, Hematology, Oncology +16

Amino Acids and mTOR Mediate Distinct Metabolic Checkpoints in Mammalian G1 Cell Cycle

Mahesh Saqcena, Deepak Menon, Deven Patel et al. · PLoS ONE · 2013 · 74 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

Jordan Gauthier, Nicolas Gazeau, Alexandre V. Hirayama et al. · Blood · 2022 · 54 citations · Full text

Life Sciences, Immunology, Oncology +13

Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma

Jennifer L. Crombie, Loretta J. Nastoupil, Robert Redd et al. · Blood Advances · 2021 · 36 citations · Full text

Medicine, Oncology, Pharmacology +6